|本期目录/Table of Contents|

[1]左霞,陈红英,陈德森,等.参麦注射液对大鼠脑缺血再灌注损伤的影响[J].环球中医药,2015,8(04):407-410.[doi:10.3969/j.issn.1674-1749.2015.04.006]
 ZUO Xia,CHEN Hong-ying,CHEN De-sen,et al.Effects of Shenmai Injection on rats with cerebral ischemia reperfusion injury[J].,2015,8(04):407-410.[doi:10.3969/j.issn.1674-1749.2015.04.006]
点击复制

参麦注射液对大鼠脑缺血再灌注损伤的影响()
     
分享到:

《环球中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
第8卷
期数:
2015年04期
页码:
407-410
栏目:
论著
出版日期:
2015-04-06

文章信息/Info

Title:
Effects of Shenmai Injection on rats with cerebral ischemia reperfusion injury
作者:
左霞陈红英陈德森李英王文杰李贤玉
作者单位:442000 湖北医药学院附属十堰市太和医院骨二科(左霞、陈红英、 李英、王文杰); 湖北医药学院机能实验室(陈德森),病理生理教研室(李贤玉)
Author(s):
ZUO Xia CHEN Hong-ying CHEN De-sen et al.
No.2 Department of Orthopedics, Shiyan Taihe Hospital affiliated to Hubei University of Medicine,Shiyan 442000, China Corresponding author:LI Xian-yu,E-mail:cdscds1226@126.com
关键词:
参麦注射液 大鼠脑缺血 再灌注损伤 局部脑血流 脑电图 梗死范围
Keywords:
Shenmai Injection Cerebral ischemia Reperfusion injury Cerebral blood flow Electroencephalogram Infarction range
分类号:
R285.5
DOI:
10.3969/j.issn.1674-1749.2015.04.006
文献标志码:
A
摘要:
目的 研究参麦注射液对大鼠脑缺血再灌注损伤的保护作用及机制。方法 SD大鼠40只随机分为对照组、模型组及参麦组,模型组及参麦组均经右侧颈动脉线栓大脑中动脉Willis环,阻断血流30分钟后再灌注30分钟,并反复3次的方法,建立大鼠脑缺血再灌注损伤的模型。采用尾静脉给药,每天1次,连续6天,对照组给予等体积生理盐水。观测缺血再灌注0、30、60分钟及1天、3天、6天共计6个时间点局部脑血流量(regional cerebral blood flow,RCBF)及脑电图(electroencephalogram,EEG)棘波振幅。并计算脑缺血再灌注前及6天后脑梗死范围。结果 参麦注射液组在第3天、6天2个时点测得值显示RCBF显著升高、EEG棘波波幅明显降低,显著降低再灌注6天后脑梗死范围,与模型组比较,差异均有统计学意义(P<0.05)。结论 参麦注射液对大鼠脑缺血再灌注损伤有保护作用,作用机制可能与其具有抑制大鼠脑缺血再灌注后大脑异常放电,降低血管平滑肌细胞膜Na+-K+-ATP酶活性,松弛脑血管平滑肌改善微循环增加脑血流量有关。
Abstract:
Objective To study the protective effect and mechanism of Shenmai Injection on rats with cerebral ischemia reperfusion injury.Methods 40 SD rats were randomly divided into control group, model group and Shenmai Injection group. Model group and Shenmai Injection group were treated by right carotid artery thread embolism of middle cerebral artery Willis ring, blocking blood flow for 30 min and conducting reperfusion for 30 min. This method is repeated 3 times to construct rat models of cerebral ischemia reperfusion injury. Caudal vein administration was conducted, 1 times a day for 6 consecutive days. The control group was given normal saline with the same volume as model group and Shenmai Injection group. After ischemia reperfusion for 0, 30, 60 min and 1d, 3d, 6d, cerebral blood flow(regional cerebral time blood flow(RCBF)and electroencephalogram(EEG)spike wave amplitude at 6 time spots were observed. Cerebral infarction range before and 6d after cerebral ischemia reperfusion was calculated. Results RCBF increased significantly and EEG spike wave amplitude decreased markedly in the 3rd day and 6th day in the Shenmai Injection group, which significantly reduced the cerebral infarction range after 6d of reperfusion. Compared with the model group, the difference was statistically significant(P<0.05). Conclusion Shenmai Injection has protective effect on rats with cerebral ischemia reperfusion injury. The mechanism of action may be associated with the inhibition of abnormal discharge in the rat's brain after cerebral ischemia reperfusion, the reduction of enzyme activity of vascular smooth muscle cell membrane Na+-K+ - ATP, the relaxation of cerebrovascular smooth muscles, the improvement of microcirculation and the increase of cerebral blood flow.

参考文献/References:

[1] Cheng J Y, Huang J C, Liu GY, et al. Effect of shenmai injection on the expression of hippocampal c-fos gene of rats with ischemic cerebral injury[J]. Chinese Journal of Clinical Rehabilitation,2005,9(32):228-229.
[2] 曹旭东,丁志山,陈建真,等. 参麦注射液药理及临床研究进展[J].中国中医药信息杂志,2010,17(3):104-106.
[3] 徐艳炜, 孙莉, 梁浩,等. 脑缺血中12/15-脂氧合酶对过氧化物酶体增殖物激活受体γ调节作用的初步探讨[J]. 中华神经科杂志, 2014,47(2): 123-127.
[4] Felberg RA,Burgin WS,Grotta JC. et al.Neuroprotection and the ischemic cascade[J].CNS Spectrums,2000,5(3):52- 58.
[5] 王婷,闫咏梅,曹影,等.参麦注射液治疗中风(恢复期)瘀血闭阻证的临床研究[J].中西医结合心脑血管病杂志,2014,12(2):148-149.
[6] 沈斌,董广佩,方久强,等.早期运用参麦注射液联合大剂量纳洛酮治疗重型颅脑损伤疗效观察[J].现代中西医结合杂志, 2011,(22):2761-2762.
[7] 欧阳修河,尹睿,张颍,等.参麦注射液对无创通气治疗慢性阻塞性肺病并严重呼吸衰竭的影响[J].中国中西医结合杂志,2006,26(7):608- 611.
[8] Spinale FG,Coker MI,Bond BR,et al.Myocardial matrix degradation and metallopro teinase activation in the failing heart:A potentialtherapeutic target[J].Cardiovasc Res,2000,46(2):225-238.

相似文献/References:

备注/Memo

备注/Memo:
基金项目:湖北医药学院研究生启动基金(2008QDJ9) 作者简介: 陈红英(1967- ),女,本科,主管护师。研究方向:临床药理学及外科护理。E-mail:951777718qq@.com 通讯作者:李贤玉(1979- ),女,硕士,讲师。研究方向:病理生理特点及临床药理学。E-mail:cdscds1226@126.com
更新日期/Last Update: 2015-04-20